Antithrombotic Guideline - NHS Borders | Right Decisions

Section 1: Introduction

Section 2: Prophylaxis of Venous Thromboembolism (VTE) with Low Molecular Weight Heparin (LMWH)

Section 3: Treatment of Venous Thromboembolism (VTE) with low molecular weight heparin (LMWH)

Section 4: Unfractionated Heparin (UFH) and Heparin-induced Thrombocytopenia (HIT)

Section 5: Direct Oral Anticoagulants (DOACs) for Treatment and Prophylaxis of Venous Thromboembolism (VTE)

Last reviewed: 31/12/2025

Next review date: 31/12/2027

Author(s): McKaig, R.

Version: v1.0

Approved By: NHS Borders Area Drug & Therapeutic Committee

Reviewer name(s): McKaig, R.